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Abstract: As multiple different treatment options are available for prostate cancer (PCa) and YouTube
is commonly used as a source for medical information, we performed a systematic and comparative
assessment of available videos guiding patients on their choice for the optimal treatment. An
independent search for surgical therapy or radiotherapy of PCa on YouTube was performed and the
40 most viewed videos of both groups were analyzed. The validated DISCERN questionnaire and
PEMAT were utilized to evaluate their quality and misinformation. The median overall quality of the
videos was found to be low for surgery videos, while radiotherapy videos results reached a moderate
quality. The median PEMAT understandability score was 60% (range 0–100%) for radiotherapy
and 75% (range 40–100) for surgery videos. The radiotherapy videos contained less misinformation
and were judged to be of higher quality. Summarized, the majority of the provided videos offer
insufficient quality of content and are potentially subject to commercial bias without reports on
possible conflict of interest. Thus, most of available videos on YouTube informing PCa patients
about possible treatment methods are not suited for a balanced patient education or as a basis for the
patient’s decision.
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1. Introduction
Prostate cancer (PCa) is the most common noncutaneous cancer in men with over
1 million novel cancer cases worldwide and over 300,000 deaths per year [1]. Despite
the availability of many consensus guidelines [2,3], the management and the choice of
the suitable treatment method often poses a challenge, as multiple equivalent treatment
options may be available [4–6]. Facing this uncertainty, the internet and online patient
education materials represent an important source of information for patients [7]. With
over 2 billion users monthly, YouTube is one of the most popular websites and has been
demonstrated to be a commonly used source for medical information [8,9].
This shift of health-information seeking behavior could be even reinforced by the
actual coronavirus disease 2019 (COVID-19) [10], which poses substantial challenges for
healthcare systems worldwide [11]. In times of limited resources and social distancing [12],
new healthcare services, such as consultations via telephone or video have been intro-
duced [13]. Due to the unprecedented disruption of health care services with postponed
treatments [14] online sources such as YouTube gain in importance. Accordingly, standard-
ized methods have been introduced to evaluate the accuracy and comprehensiveness of
patient education materials [15].
The specific objective of the following study was to perform a systematic and com-
parative assessment of available videos guiding patients on their choice for the optimal
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treatment of their localized PCa. While Facebook, Youtube and Twitter, as the most popular
social media websites, have been shown to be used by the general public to share health
information [16], we focused our search on YouTube, as the video only platform among
the popular websites, which has been described to be significant for medical information,
especially during the covid—pandemic [17].
2. Materials and Methods
An independent search for surgical therapy or radiotherapy (RT) of PCa on YouTube
was performed in March 2021, in English, by four of the authors. Two of the authors were
board-certified urologists (Fellow of the European Board of Urology), one author was
a board-certified radiation oncologist and one a senior resident. The video search was
conducted using associated keywords (see Supplementary text box). Only videos with an
English audio track were included, and videos solely targeting healthcare professionals
(i.e., surgical techniques, instructional explanation of device use) were excluded. Videos
containing information about both therapy options were assigned to one group based on
the main subject.
For each group, the 40 most viewed videos matching the inclusion and exclusion
criteria were included for further analysis. The videos concerning radiotherapy were
evaluated by the two radiation oncologists, while the surgery videos were assessed by
the urologists.
Basic data (video upload date, length, number of views, quality of audio and video,
disclosure) was assessed for every video. Further parameters documented were: type of
video provider (consumer/patient; healthcare [doctor, clinic, hospital, university]; industry;
news media; society/organization [foundation, governmental, academic journal]; unclear);
primary and secondary topics of the video (overall procedure; surgery indications; benefits;
risks/side effects; technical aspects); degree of misinformation compared to currently avail-
able evidence (no; very little; moderate; high; extreme); and depiction of real intervention
(yes/no).
Every video was assessed using the validated DISCERN questionnaire [18] and exam-
ined on quality and misinformation compared to the current guidelines of the European
Association of Urology (EAU) [2,3]. The DISCERN instrument was developed by an expert
panel and validated by multiple major national self-help organizations. The survey con-
sisted of 16 questions, each of which represents a separate quality criterion and is rated
from one to five points (1–2 points: low; 3 points: moderate; 4–5 points: high quality). Thus,
a total score of 80 points is possible, with higher scores indicating higher quality. As a
second systematic evaluation, the Patient Education Materials Assessment Tool for Audio-
visual Materials (PEMAT) was used [15]. The PEMAT tool was developed as a reliable and
valid instrument to assess the understandability and actionability of print and audiovisual
patient information. Thereby, PEMAT has been proven to demonstrate strong internal
consistency, reliability, and evidence of construct validity. For our study, we utilized the
version for audiovisual materials, which consist of 13 items measuring understandability
and four items measuring actionability. Descriptive analysis and Mann–Whitney U tests
were performed with IBM SPSS software version 27 (IBM, Armonk, NY, USA).
3. Results
The 80 videos included to analysis were uploaded between February 2008 (surgery)/
November 2008 (radiotherapy) and September 2019 (both). The duration of the videos
ranged from 35 s to 31 min. The most popular video was found in the surgery group
with 4,986,282 views (1 March 2021). Table 1 shows the basic data of all videos included
grouped by radiotherapy and surgery.
Most of the videos concerning radiotherapy (60%) and surgery (48%) were provided
by healthcare professionals (doctor, clinic, hospital or university). Videos provided by
patients were nearly three times more likely to be found in the surgery group (22%) than
the radiotherapy group (7.5%). Societies (foundations, governmental institutions, academic
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journals) provided 20% of the radiotherapy videos and 10% of the surgery videos. Other
providers (industry, news media) ranged between 5% and 15 % for both groups. The most
common primary topic was the overall procedure (radiotherapy: 75%, surgery: 60%), the
secondary topics of the videos varied widely between the two groups (Figure 1).
Table 1. Basic characteristic of included videos, grouped by type of treatment (radiotherapy or surgery). (Numbers are
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ias, only 10% (surgery) and 5% (radiotherapy) of the providers included a disclosure
of their conflicts of interest. For both treatment modalities assessed, 19 videos (13 about
radiotherapy [33%] and 6 about surgery [15%]) were rated to have no misinformation. In
general, videos about radiotherapy were rated to have much less misinformation than
surgery videos as demonstrated in Figure 2.
The median overall quality of the videos, according to DISCERN, was found to be
low for surgery videos (2 out of 5 points for question 16; Table 2), while radiotherapy
results reached a moderate quality (3 out of 5 points). Likewise, 75% of all DISCERN
items reached a moderate quality for radiotherapy videos while only 31% of all DISCERN
items for surgery videos were classified as moderate quality (Table 2). Adding up the
results of all DISCERN questions, radiotherapy videos also resulted in a higher score
(median 43 points, range 20.5–65) than the surgery videos (median 36.5 points, range
18–71). The Mann-Whitney test indicated that the median DISCERN scores were higher for
the radiotherapy videos than for the surgery videos (U = 65, p = 0.018).
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Table 2. DISCERN single items (median [range]) for the different treatment methods assessed.
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Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
4 3.5 3.25 3 2.5 2 2.25 2 2.5 2.5 3 1.5 2.5 2.75 3 3Radiotherapy
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Color of the boxes indicate the quality of the videos: red: low (DISCERN score 1–2.4); orange: moderate (DISCERN score 2.5–3.4): green: high (DISCERN score 3.5–5). The median PEMAT understandability score
was 60% (range 0–100%) for radiotherapy and 75 % (range 40–100) for surgery videos. Both therapy modalities reached a median PEMAT actionability of 50 % (range 0–100% (radiotherapy), 25–100% (surgery)).
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4. Discussion
In this study, we evaluated the quality of information of videos concerning the local
treatment of PCa provided on YouTube. The RT videos were rated better than the surgery
videos regarding the DISCERN questions (Table 2). In particular, RT videos were deemed
to inform the viewers better about the potential benefits and risks of each treatment.
Meanwhile, the surgery videos were rated higher in pointing out areas of uncertainty. In
regard to understandability, the PEMAT actionability displayed similar results for both
groups, with surgery videos fairing slightly better than radiotherapy videos. Noticeably,
both groups failed to inform the audience about the possibility and consequences of the
alternative of “active surveillance” strategies, as compared to the presented treatment
method. As the keywords we used for the video search included “prostate cancer therapy”
and “prostate cancer treatment” (see Supplementary text box), one would expect that the
option “active surveillance” would be at least mentioned in the 80 most-viewed videos on
Youtube. A quick search for videos with “active surveillance” in the title revealed only
a few videos, with little views; the most-viewed video had 28,100 views, compared with
1.2 million and 4.9 million views for the most-viewed RT and surgery videos, respectively.
Overall, the RT videos contained less misinformation (Figure 2) and were judged to
be of higher quality than the surgery videos. This may be in part due to the focus of RT
videos on “risks/side effects” and “therapy indication” compared with the surgery videos.
Remarkably, sexual dysfunction, as a side effect of surgery and reported to significantly
influence patients quality of life [19,20], was rarely mentioned in the surgery videos. This
lack of information may be as important as misinformation for the treatment decision-
making. Furthermore, the fact that a larger part of the RT videos was provided by health
care professionals and societies as opposed to patients could also be a further explanation.
At least, the Mann-Whitney test showed a significant difference of median DISCERN
scores between all assessed videos by professionals/societies and patient videos (U = 67.5,
p < 0.05).
Clearly, some parts of the analyses represent subjective assessments, such as the rating
of the extent of misinformation. By using the validated DISCERN and PEMAT question-
naires and the evaluation of two independent judges for each group, we attempted to
minimize this subjectivity as much as possible. With the broad spectrum of quality criteria,
the utilized scores are reported to be suitable methods for analyzing different consumer
health-information materials [15,21,22]. To our knowledge, our analysis constitutes the
first multidisciplinary analysis of an oncological condition amendable to treatment by two
different specialties.
The currently available data for localized prostate cancer indicates that radiotherapy
and surgery can be considered equivalent treatment options, with comparably high rates of
long-term cancer control, from an oncological point of view, in most clinical scenarios. It is
therefore of utmost importance to assist patients in making an informed choice regarding
their preferred treatment [23]. While both methods are recommended in the current EAU
guideline [2,3], the advantages and disadvantages of each treatment method differ and
might influence a patient’s decision. With external-beam RT, surgery-associated complica-
tions such as bleeding, transfusion-related effects or anesthesia-associated risks could be
avoided [24], however the treatment with RT is associated with a treatment course over
several weeks and higher risks for rectal symptoms from radiation proctitis [25]. On the
other hand, radical prostatectomy is a suitable therapy option recommended for patients
with a life expectancy of at least 10 years [26,27]. In recent years, the increased use of
minimally invasive surgery has led to reduced hospital time, less blood transfusions and
fewer surgical complications as compared to open surgery [28]. Simultaneously, the intro-
duction of modern image-guided RT techniques, such as volumetric modulated arc therapy
(VMAT), has led to a reduction in acute gastrointestinal toxicity due to radiotherapy [29].
This brief description of the advances and the side effects caused by the different treatment
methods illustrates the challenging situation for the PCa patient.
Curr. Oncol. 2021, 28 3426
For decision-making, a detailed guidance and consultation from an interdisciplinary
PCa team is crucial. The disruption of health care systems by the global COVID-19 pan-
demic [30,31], with its incumbent scarcity of resources [32], poses special difficulties to the
fair and sufficient guidance of PCa patients [33]. While the European Association of Urology
(EAU) advocated the delay of radical prostatectomy until after the pandemic [34], several
studies described no outcome differences between the sequence of androgen-deprivation
therapy and external-beam RT [35]. These findings also might justify the delay of prostate
RT until COVID-19 infection rates decrease [36].
It is obvious that these developments and the limited availability of health care services
with reduced consultations and postponed treatments [37,38] reinforce the importance of
online patient-education materials. Also, the trend towards shared decision-making [39], in
which patient education is a pivotal cornerstone [40], amplifie this development. Therefore,
video platforms like YouTube, with large numbers of consumers, play a prominent role in
patient education. While the EAU [41] and the American Urological Association (AUA) [42]
each provide a YouTube channel with regularly updated content, the American Society
for Radiation Oncology (ASTRO) rarely uploads videos, and with very limited reach [43].
The European Society for Radiation Oncology (ESTRO) does not have a YouTube channel,
demonstrating the pent-up demand for the supply of online patient-education material of
sufficient quality and information.
Our present study had some limitations. First, only English videos were included in our
assessment. Second, video analyses always faced significant subjectivity (e.g., assessment
of the extent of misinformation). Of particular importance is the fact, that the specialists
rated the respective videos, thereby limiting the validity of a direct comparison between the
groups (e.g., if one group is, in general, more critical than the other). A “cross-validation”
between the two groups by the different specialists could have helped to decrease this
potential bias; but, on the other hand, such an approach would weaken the fact that
specialists assessed the videos of their subject, which offers advantages for the evaluation
of the grade of information provided, especially where details are concerned, e.g., special
RT methods. To address this limitation and to objectify the analyses, we used validated
tools such as the DISCERN questionnaire and the PEMAT score. Nevertheless, the nature of
video analysis remains, to a certain degree, subjective.
Our evaluation of videos concerning the treatment methods of PCa confirms the
findings of previous studies [44,45]: the majority of the provided videos offer insufficient
quality of content and are potentially subject to commercial bias, without reporting on
possible conflicts of interest. Thereby, bias was defined as the intention to show inclinations
for a treatment method instead of objectively informing the patients. In particular, the
surgery videos often contained advertising for robotic-assisted surgery, a high-technology
alternative which is reported to increase direct and indirect health-care costs [46]. This
gives the impression that some treatment methods have been strongly marketed without
balanced information about alternative methods. With this masked bias, some of the
available videos on YouTube informing PCa patients about the appropriate surgical method
do not qualify for a balanced patient education or as a basis for the patient’s decision. To
satisfy this urge for information, the international and national societies (EAU, AUA,
ASTRO, ESTRO, etc.) and local health care providers should increase their efforts and
extend the offered online patient-education materials. To achieve significant reach, popular
media platforms, such as YouTube, should be addressed with balanced and evidence-
based information.
5. Conclusions
The majority of the provided videos about surgery and radiotherapy of localized PCa
offer insufficient quality of content and are potentially subject to commercial bias, without
reporting their possible conflict of interest. Thus, most of the available videos on YouTube
informing PCA patients about possible treatment methods are not suited for a balanced
patient education or as a basis for the patient’s decision.
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